Cidara Therapeutics, Inc. — Form D

Cidara Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-06. The offering totals $240.0M, of which $240.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Bonnie R Bassler, Ph.D.DirectorSan Diego, CA
Carin R Canale-TheakstonDirectorSan Diego, CA
James R Merson, Ph.D.DirectorSan Diego, CA
Ryan R SpencerDirectorSan Diego, CA
Jeffrey Stein, Ph.D.DirectorSan Diego, CA
Laura R Tadvalkar, Ph.D.DirectorSan Diego, CA
Taylor R Sandison, M.D.Executive OfficerSan Diego, CA
Preetam R Shah, Ph.D.Executive OfficerSan Diego, CA
Jeffrey Stein, Ph.D.Executive OfficerSan Diego, CA
Leslie R Tari, Ph.D.Executive OfficerSan Diego, CA
Shane R WardExecutive OfficerSan Diego, CA
Daniel D BurgessDirectorSacramento, CA
Dirk ThyeExecutive OfficerSouth San Francisco, CA
Nina KjellsonDirectorSanta Clara, CA
Patrick HeronDirectorPhiladelphia, PA
Kevin JudiceDirectorSouth San Francisco, CA
Kevin JudiceExecutive OfficerSouth San Francisco, CA
Jeffrey SteinDirectorSan Francisco, CA
Jeffrey SteinExecutive OfficerSan Francisco, CA
Scott RocklageDirectorMenlo Park, CA
Theodore R SchroederDirectorSan Diego, CA
David R GollaherDirectorSan Diego, CA
Timothy R FransonDirectorSan Diego, CA
Jessica R OienExecutive OfficerSan Diego, CA
Taylor R SandisonExecutive OfficerSan Diego, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2019-09-13D$9.0M$9.0M
2018-05-30D$1.9M$1.6M
2017-10-31D$20.2M$20.2M
2015-02-17D$42.0M$42.0M
2014-06-17D$42.7M$30.3M
2014-06-17D$6.0M$6.0M

More